Metastatic adenocarcinoma of unknown primary origin

Human Pathology

Volumn 29, Issue 12, 1998, Pages 1393-1402

  Hammar, Samuel P ^a  

^a Diagnostic Specialties Laboratory Inc   (United States)

Author keywords

Adenocarcinomas; Electron microscopy; Immunohistochemistry; Metastatic; Neoplasms unknown origin

Indexed keywords

CYTOKERATIN 7; ESTROGEN; MEMBRANE PROTEIN; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; THYROGLOBULIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANTIGEN SPECIFICITY; CELL ULTRASTRUCTURE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; PROTEIN LOCALIZATION; REVIEW;

EID: 0031699673     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90007-7     Document Type: Editorial

References (44)

1. Krementz ET, Cerise EJ, Foster DS, et al: Metastases of undetermined source. Curr Prob Cancer 4:4-37, 1979
2. Moertel CG, Reitemeier J, Schutt AJ, et al: Treatment of the patient with adenocarcinoma of unknown origin. Cancer 30:1469-1472, 1972
3. Nissenblatt MJ: CUP syndrome (carcinoma unknown primary). Cancer Treat Rev 8:211-224, 1981
4. Fer MF, Greco A, Oldham RK (eds): Poorly differentiated neoplasms and tumors of unknown origin. Semin Oncol 9:393-395, 1982
5. Stewart JF, Tattersal MHN, Woods RL, et al: Unknown primary adenocarcinoma; incidence of over-investigation and natural history. Br MedJ 1:1530-1533, 1979
6. Gilman A, Fordham E, Wiley E, et al: Metastatic carcinoma with unknown primary. Med Ped Oncol 12:59-63, 1984
7. Hainsworth JD, Greco FA: Treatment of patients with cancer of an unknown primary site. N EnglJ Med 329:257-263, 1993
8. Hammar S, Bockus D, Remington F: Metastatic tumors of unknown origin: An ultrastructural analysis of 265 cases. Ultrastruct Pathol 11:209-250, 1987
9. Patchell RA, Tibbs PA, Walsh JW, et al: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 332:494-500, 1991
10. Sauter ER, Bolton JS, Willis GW, et al: Improved survival after pulmonary resection of metastatic colorectal carcinoma. J Surg Oncol 43:135-138, 1990
11. Kirsten F, Chi CH, Leary JA, et al: Metastatic adeno or undifferentiated carcinoma from an unknown primary site: Natural history and guidelines for identification of treatable subsets. QJM 62:143-161, 1987
12. Shehan K, O'Keane JC, Abramowitz A, et al: Metastatic adenocarcinoma of unknown primary site: A comparison of the relative contributions of morphology, minimal essential clinical data, and CEA immunostaining status. Am J Clin Pathol 99:729-735, 1993
13. Hammar SP: Pleural diseases, 1526-1550, in Hammar SP (eds): Dail DH, Pulmonary Pathology (ed 2). New York, Springer-Verlag Inc, 1994, pp 1463-1580
14. Hammar SP, Bockus DE, Remington FL, et al: Mucin-positive epithelial mesotheliomas: A histochemical, immunohistochemical and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas. Ultra Pathol 20:293-325, 1996
15. Osborne BM, Mackay B, Butler JJ, et al: Large cell lymphoma with microvillus-like projections; an ultrastructural study. Am J Clin Pathol 79:443-450, 1983
16. Nagle RB: Intermediate filaments: Efficacy in surgical pathologic diagnosis. Am J Clin Pathol 91:S14-S18, 1989 (Suppl 1)
17. Loy TS, Calaluce RD: Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 102:764-767, 1994
18. Wang NP, Zee S, Zarbo RJ, et al: Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohist 3:99-107, 1995
19. Savera AT, Torres FX, Linden MD, et al: Primary versus metastatic pulmonary adenocarcinoma: An immunohistochemical study using villin and cytokeratins 7 and 20. Appl Immunohist 4:86-94, 1996
20. Berezowski K, StastnyJR, Karnstein MJ: Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9:426-429, 1996
21. Maeda T, Kajiyama K, Adachi E, et al: The expression of cytokeratins 7, 19 and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 9:901-909, 1996
22. Ma CK, Zarbo RJ, Frierson HF, Jr, et al: Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 99:551-557, 1993
23. Raab SS, Berg LC, Swanson PE, et al: Adenocarcinoma in the lung in patients with breast cancer; a prospective analysis of the discriminatory value of immunohistology. AmJ Clin Pathol 100:27-35, 1993
24. Ollayos CW, Riordan P, Rushin JM: Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas and lung. Arch Pathol Lab Med 118:630-632, 1994
25. Canver CC, Memoli VA, Vanderveer PL, et al: Sex hormones in non-small cell lung cancer in human beings. J Thorac Cardiovasc Surg 108:153-157, 1994
26. Bacchi CE, Garcia RL, Gown AM: Immunolocalization of estrogen and progesterone receptors in neuroendocrine tumors of lung, skin, gastrointestinal and female genital tracts. Appl Immunohist 5:17-22, 1997
27. Bejarano PA, Baughman RP, Biddinger PW, et al: Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9:445-452, 1996
28. Ordonez NG, Mackay B: The roles of immunohistochemistry and electron microscopy in distinguishing epithelial mesothelioma of the pleura from adenocarcinoma. Adv Anat Pathol 3:273-293, 1996
29. Brown RW, Campagna LB, Dunn JK, et al: Immunohistochemical identification of tumor markers in metastatic adenocarcinoma: A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 107:12-19, 1997
30. Thor A, Ohuchi N, Szpac CA, et al: Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 46:3118-3124, 1986
31. Loy TS, Nashelsky MB: Reactivity of B72.3 with adenocarcinomas: An immunohistochemical study of 476 Cases. Cancer 72:2495-2498, 1988
32. Mesa-Jejada R, Palakodety RB, Leon JA, et al: Immunocytochemical distribution of a breast carcinoma associated glycoprotein identified by monoclonal antibodies. Am J Pathol 130:305-314, 1998
33. Loy TS, Chapman RK, Diaz-Arias AA, et al: Distribution of BCA-225 in adenocarcinomas: An immunohistochemical study of 446 cases. Am J Clin Pathol 96:326-329, 1991
34. Akasofu M, Kawaham E, Kurumaya H, et al: Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver. Acta Pathol Jpn 43:736-744, 1993
35. Wick MR, Lillemoe JJ, Copland GT, et al: Gross cystic disease fluid protein-15 as a marker for breast carcinoma. Hum Pathol 20:281-287, 1989
36. Raab SS, Berg LC, Swanson PE, et al: Adenocarcinoma in the lung in patients with breast cancer. A prospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol 100:27-35, 1993
37. Wick MR: Monoclonal antibodies to carcinoembryonic antigen in diagnostic immunohistochemistry, in Wick MR, Siegal GD (eds) : Monoclonal Antibodies in Diagnostic Immunohistochemistry. New York, NY, Marcel Dekker, 1988, pp 539-567
38. Sheahan K, O'Brien MJ, Burke B, et al: Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Am J Clin Pathol 94:157-164, 1990
39. Dietel M, Arps H, Klapdor R, et al: Antigen detection by the monoclonal antibodies CA 19-9 and CA125 in normal and tumor tissue and patient's sera. J Can Res Clin Oncol 111:257-265, 1986
40. Loy TS, Sharp SC, Andershock CJ, et al: Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas: An immunohistochemical study of 527 cases. Am J Clin Pathol 99:726-728, 1993
41. Gatalica Z, Miettinen M: Distribution of carcinoma antigens CA 19-9 and CA 15-3: An immunohistochemical study of 400 tumors. Appl Immunohistochem 2:205-211, 1994
42. Koelma IA, Nap M, Rodenburg CJ, et al: The value of tumor marker CA 125 in surgical pathology. Histopathology 11:287-294, 1987
43. Loy TS, QuesenberryJT, Sharp SC: Distribution of CA125 in adenocarcinomas: An immunohistochemical study of 481 cases. Am J Clin Patholo 98:175-179, 1992
44. Mauri FA, Veronese S, Frigo B, et al: ERID5 and H222 (ER-ICA) antibodies to human estrogen receptor in breast carcinomas: Results of multicentric comparative study. Appl Immunohistochem 2:157-163, 1994